Related Experiment Video
Updated: Dec 4, 2025

Detection of Detergent-sensitive Interactions Between Membrane Proteins
Published on: March 7, 2018
TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes
Sharon C Hook1, Alexandra Chadt2,3, Kate J Heesom1
1School of Biochemistry, Biomedical Sciences Building, University of Bristol, University Walk, Bristol, BS8 1TD, UK.
Abstract:
Proteins involved in the spaciotemporal regulation of GLUT4 trafficking represent potential therapeutic targets for the treatment of insulin resistance and type 2 diabetes. A key regulator of insulin- and exercise-stimulated glucose uptake and GLUT4 trafficking is TBC1D1. This study aimed to identify proteins that regulate GLUT4 trafficking and homeostasis via TBC1D1. Using an unbiased quantitative proteomics approach, we identified proteins that interact with TBC1D1 in C2C12 myotubes including VPS13A and VPS13C, the Rab binding proteins EHBP1L1 and MICAL1, and the calcium pump SERCA1. These proteins associate with TBC1D1 via its phosphotyrosine binding (PTB) domains and their interactions with TBC1D1 were unaffected by AMPK activation, distinguishing them from the AMPK regulated interaction between TBC1D1 and AMPKα1 complexes. Depletion of VPS13A or VPS13C caused a post-transcriptional increase in cellular GLUT4 protein and enhanced cell surface GLUT4 levels in response to AMPK activation. The phenomenon was specific to GLUT4 because other recycling proteins were unaffected. Our results provide further support for a role of the TBC1D1 PTB domains as a scaffold for a range of Rab regulators, and also the VPS13 family of proteins which have been previously linked to fasting glycaemic traits and insulin resistance in genome wide association studies.
Insights
Researchers identified new proteins, VPS13A and VPS13C, that interact with TBC1D1 to regulate glucose transporter type 4 (GLUT4) trafficking. This discovery offers potential therapeutic targets for insulin resistance and type 2 diabetes.
Area of Science:
- Cell biology
- Molecular endocrinology
- Metabolic disease research
Background:
- Insulin resistance and type 2 diabetes are linked to impaired glucose uptake, with GLUT4 trafficking being a critical regulatory process.
- TBC1D1 is a key protein controlling glucose uptake and GLUT4 trafficking in response to insulin and exercise.
- Identifying TBC1D1-interacting proteins is crucial for understanding and targeting metabolic dysregulation.
Purpose of the Study:
- To identify novel proteins that interact with TBC1D1 and regulate GLUT4 trafficking and homeostasis.
- To investigate the role of these TBC1D1-interacting proteins in the context of insulin resistance and diabetes.
Main Methods:
- Unbiased quantitative proteomics was employed to identify TBC1D1-interacting proteins in C2C12 myotubes.
- Protein interactions were analyzed, focusing on associations via TBC1D1's phosphotyrosine binding (PTB) domains.
- Gene depletion studies (VPS13A, VPS13C) were performed to assess their impact on GLUT4 levels and cell surface expression.
Main Results:
- Proteomics identified VPS13A, VPS13C, EHBP1L1, MICAL1, and SERCA1 as TBC1D1 interactors.
- These proteins bind to TBC1D1 via its PTB domains, independently of AMPK activation.
- Depletion of VPS13A or VPS13C led to increased cellular and cell surface GLUT4 levels, specifically for GLUT4, upon AMPK activation.
Conclusions:
- The TBC1D1 PTB domains act as a scaffold for various Rab regulators, including VPS13A and VPS13C.
- VPS13 proteins play a significant role in regulating GLUT4 trafficking and cellular glucose uptake.
- These findings highlight VPS13 proteins as potential therapeutic targets for managing insulin resistance and type 2 diabetes.
Related Concept Videos
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Vesicular Tubular Clusters
With the help of motor proteins such...
Insulin Secretory Vesicles
Transport Across the Golgi
Intralumenal Vesicles and Multivesicular Bodies
PI3K/mTOR/AKT Signaling Pathway

